Q2 2016 13F Holders as of 6/30/2016
-
Type / Class
-
Equity / Common Stock, $0.00001 par value per share
-
Shares outstanding
-
174M
-
Number of holders
-
37
-
Total 13F shares, excl. options
-
14.2M
-
Shares change
-
+199K
-
Total reported value, excl. options
-
$294M
-
Value change
-
+$6.8M
-
Number of buys
-
28
-
Number of sells
-
-10
-
Price
-
$20.69
Significant Holders of Wave Life Sciences Ltd. - Common Stock, $0.00001 par value per share (WVE) as of Q2 2016
42 filings reported holding WVE - Wave Life Sciences Ltd. - Common Stock, $0.00001 par value per share as of Q2 2016.
Wave Life Sciences Ltd. - Common Stock, $0.00001 par value per share (WVE) has 37 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 14.2M shares
of 174M outstanding shares and own 8.14% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, LLC (7.09M shares), FMR LLC (1.86M shares), Redmile Group, LLC (1.1M shares), Foresite Capital Management III, LLC (970K shares), New Leaf Venture Partners, L.L.C. (784K shares), PERCEPTIVE ADVISORS LLC (523K shares), Cormorant Asset Management, LLC (394K shares), EVENTIDE ASSET MANAGEMENT, LLC (380K shares), Clough Capital Partners L P (263K shares), and BlackRock Fund Advisors (193K shares).
This table shows the top 37 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.